Cdc42 mediates bone resorption principally by stimulating osteoclastogenesis. Whether its sister GTPase, Rac, meaningfully impacts upon the osteoclast and, if so, by what means, is unclear. We find that whereas deletion of Rac1 or Rac2 alone has no effect, variable reduction of Rac1 in osteoclastic cells of Rac2 2/2 mice causes severe osteopetrosis. Osteoclasts lacking Rac1 and Rac2 in combination (Rac double-knockout, RacDKO), fail to effectively resorb bone. By contrast, osteoclasts are abundant in RacDKO osteopetrotic mice and, unlike those deficient in Cdc42, express the maturation markers of the cells normally. Hence, the osteopetrotic lesion of RacDKO mice largely reflects impaired function, and not arrested differentiation, of the resorptive polykaryon. The dysfunction of RacDKO osteoclasts represents failed cytoskeleton organization as evidenced by reduced motility of the cells and their inability to spread or generate the key resorptive organelles (i.e. actin rings and ruffled borders), which is accompanied by abnormal Arp3 distribution. The cytoskeleton-organizing capacity of Rac1 is mediated through its 20-amino-acid effector domain. Thus, Rac1 and Rac2 are mutually compensatory. Unlike Cdc42 deficiency, their combined absence does not impact upon differentiation but promotes severe osteopetrosis by dysregulating the osteoclast cytoskeleton.
Introduction
Bone resorption is the unique purview of the osteoclast (Teitelbaum, 2007) . This polykaryon is the product of targeted differentiation and fusion of monocyte and/or macrophage precursors under the aegis of macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kappa B ligand (RANKL). Osteoclastic bone resorption involves generation of an isolated resorptive microenvironment immediately external to the bone-apposed plasma membrane. By acidifying this compartment, osteoclasts mobilize the mineral phase of skeletal tissue, and the exposed organic matrix is cleaved by secreted cathepsin K. Knowledge of the bone-degrading molecules, transported into the resorptive microenvironment, has yielded anti-osteoporosis therapeutic candidates and suggests that additional targets might be discovered by delineating osteoclastactivating signals (Eisman et al., 2011) .
Like all cells, the ability of osteoclasts to fulfill their biological mission depends on the organization and polarization of their cytoskeleton. Upon osteoclast-bone contact, acidifying vesicles of lysosomal origin migrate towards, and insert into, the boneapposed plasma membrane, thereby increasing its complexity, to form the resorptive organelle of the cell, the ruffled border. Isolation of the resorptive microenvironment, which contains the ruffled border and bone-degrading molecules, from the general extracellular space, is achieved by its inclusion within an actinrich sealing zone or ring (Zhao et al., 2008) .
Rho GTPases organize the actin cytoskeleton (Heasman and Ridley, 2008) by cycling between active GTP-and inactive GDPbound states (Heasman and Ridley, 2008) . These molecules regulate events such as cell migration, spreading and adhesion (Jaffe and Hall, 2005) . They also promote vesicle transport and microtubule polarization. The impact of Rho GTPases is not limited to the cytoskeleton as they regulate morphogenesis, cell cycle and gene expression. Organization of the osteoclast cytoskeleton is initiated by activation of the avb3 integrin (McHugh et al., 2000) . Deletion of the integrin, or any of its effector molecules, impairs cytoskeletal organization and function, yielding a common phenotype in which the polykaryon fails to spread or normally resorb bone both in vitro and in vivo (Faccio et al., 2005; McHugh et al., 2000; Reeve et al., 2009; Zou et al., 2007; Zou et al., 2010) . The avb3-integrin-stimulated cytoskeleton-organizing complex includes the ITAM-domain-containing protein Dap12 (also known as Tyrobp), the adaptor SLP76 (also known as Lcp2) and the tyrosine kinases Src and Syk, which activates Vav3. Vav3 is a relatively osteoclast-specific guanine-nucleotide-exchange factor (GEF), which mediates the transition of Rac to its active GTPbound form (Faccio et al., 2005) .
Cdc42 and Rac are Rho family GTPases whose biological properties are both overlapping and distinct (Gu et al., 2003) . We recently established that Cdc42 regulates osteoclastic bone resorption (Ito et al., 2010) . Although this GTPase impacts upon the cytoskeleton, it principally exerts its resorptive effects by modulating osteoclast number through enhanced precursor proliferation and retarded apoptosis of the mature polykaryon. Whether Rac meaningfully regulates osteoclasts and, if so, by what means, is unclear.
There are three highly homologous mammalian Rac GTPases, Rac1, Rac2 and Rac3. Rac2 is hematopoietic-cell-specific, whereas Rac1 is widely expressed. Rac3 is present in neurons as well as malignant tissue (Haataja et al., 1997; Morris et al., 2000) . As osteoclasts express Rac1 and Rac2, we investigated whether these GTPases regulate the bone resorbing capacity of the cell. We find combined deletion of both isoforms in the polykaryon arrests bone resorption and yields severe osteopetrosis. Rac regulates bone degradation by promoting cytoskeletal organization, and its osteoclastic properties differ from those of Cdc42. Rac isoforms are therefore distal and crucial mediators of matrix-derived signals that do not alter osteoclast differentiation but endow the mature polykaryon with its bone-degrading capability.
Results

Deletion of Rac1 in osteoclasts
Global deletion of Rac2 yields healthy fertile mice with no detectable gross bone phenotype. Systemic absence of Rac1, however, causes embryonic lethality (Sugihara et al., 1998) . We therefore utilized mice bearing loxP sites encompassing the Rac1 exon1 (Gu et al., 2003) . Combined Rac1 and Rac2 deletion in osteoclasts, was initiated by crossing Rac2 2/2 and Rac1 f/f animals (Rac1 f/f Rac2 2/2 ). Mice bearing Rac1 f/f alone or in combination with the Rac2-knockout were mated to those expressing Cre recombinase driven by the lysozyme M (LysM) promoter, which targets all myeloid and macrophage cells including those of the osteoclast lineage (Clausen et al., 1999) . This approach, however, yielded no greater than 60% deletion of Rac1 in bone marrow macrophages (BMMs) and no skeletal abnormality whether the isoform was targeted alone or combined with absence of Rac2.
Reasoning that the lack of skeletal change might reflect insufficient Rac1 deletion, we generated wild-type (WT), Rac1 f/f and Rac1 f/f Rac2 2/2 mice bearing two copies of LysMCre. Immunoblotting of BMM cell extracts isolated from these mice revealed a .90% deletion of Rac1 (supplementary material Fig. S1 ). Mice in which Rac1 was deleted in osteoclast lineage cells alone, or combined with global absence of Rac2, are referred to as LysMRac1 DOCDOC and LysMRacDKO, respectively.
Absence of Rac in osteoclast lineage cells causes severe osteopetrosis
As assessed by microtomography (micro-CT), the distal femurs of seven-week-old LysMRac1 DOCDOC and Rac2 2/2 mice were indistinguishable from those in WT mice ( Fig. 1A ; supplementary material Fig. S2 ). By contrast, LysMRacDKO animals exhibited a marked increase in skeletal mass, which was also evident radiographically ( Fig. 1A,B ; supplementary material Fig. S2 ). By histological examination, LysMRacDKO mice had classical osteopetrosis (Tolar et al., 2004) . Specifically, the failure to resorb the primary spongiosa resulted in accumulation of 'cartilaginous bars' encompassed within bone matrix, as evident in sections stained with Toludine Blue (Fig. 1C) . Characteristic of osteopetrosis due to resorptive cell dysfunction, LysMRacDKO bone contained an abundance of TRAP-expressing differentiated osteoclasts (Fig. 1D) . Reflecting their inability to adequately resorb bone in vivo, LysMRacDKO osteoclasts were not normally juxtaposed to bone and were abundant, large and irregular (Fig. 1D , lower panels), phenotypes that are also typically observed in human osteopetrosis (Coccia et al., 1980) .
LysMRacDKO osteoclasts are dysfunctional
To confirm that the enhanced bone mass of LysMRacDKO mice reflects arrested resorption, we generated osteoclasts on bone slices by culturing BMMs from control and Rac-knockout mice by treatment with RANKL and M-CSF. After 7 days, the medium was collected, cells removed by mechanical disruption and resorption pits visualized by wheat-germ-agglutinin-lectin staining. Although WT, LysMRac1 DOCDOC and Rac2
2/2
osteoclasts generated abundant resorption lacunae, these excavations were virtually absent in bone slices bearing cells in which both isoforms were lacking ( Fig. 2A ). Confirming these morphological observations, LysMRac1 DOCDOC and Rac2
osteoclasts mobilized equivalent amounts of the bone-derived collagen degradation product C-terminal telopeptides (CTx), whereas this resorption marker was virtually absent in medium obtained from LysMRacDKO osteoclasts on bone (Fig. 2B) . The abundance of osteoclasts in LysMRacDKO mice suggests that the osteopetrotic lesion reflects resorptive cell dysfunction rather than arrested osteoclastogenesis. To determine the impact of Rac isoform deletion on osteoclast number, we cultured WT and mutant BMMs with RANKL and M-CSF for 6 days and counted the number of TRAP-expressing polykaryons. Deletion of either Rac1 or Rac2, alone did not impact upon osteoclast number in vitro (supplementary material Fig. S3 ), but the abundance of cells lacking both Rac isoforms decreased ,30% (Fig. 3A) . By contrast, maturation was unaffected by absence of Rac, as osteoclast differentiation markers appeared in normal temporal sequence in BMM-derived osteoclasts lacking Rac1, or Rac1 and Rac2 (Fig. 3B) . Similarly, osteoclast precursor abundance in freshly isolated bone marrow was unaltered, as evidenced by quantification of myeloid cells (CD11b+) including macrophages (CD11b+ F4/80+) (Fig. 3C ). By contrast, LysMRacDKO pre-fusion osteoclast apoptosis was increased and RANKL-induced phosphorylation of the pro-survival signaling molecule AKT was impaired (Fig. 3D,E ).
Rac activation in the osteoclast requires avb3 integrin and is distal to a series of integrin-stimulated effectors (Faccio et al., 2003b) . Absence of avb3 integrin, or any of a complex of intermediary signaling molecules it activates, results in a common phenotype in which the cytoskeleton of the osteoclast is disrupted. By consequence, the cell fails to spread or normally resorb bone. As Rac is a distal component of this integrinactivated signaling complex, we asked whether its absence prompts the same phenotype in bone-resorptive polykaryons. To this end, we cultured WT, LysMRac1 DOCDOC , Rac2 2/2 and LysMRacDKO BMMs with M-CSF and RANKL for 5 days, to generate osteoclasts. As seen in Fig. 4A , LysMRac1
DOCDOC and Rac2 2/2 osteoclasts expressed TRAP, and were multinucleated, well spread and indistinguishable from WT cells. Although LysMRacDKO cells were also multinucleated and produced TRAP, they failed to normally spread and appeared similar to cells lacking avb3 integrin or more proximal integrin-activated signaling molecules (Faccio et al., 2005; McHugh et al., 2000; Reeve et al., 2009; Zou et al., 2007; Zou et al., 2010) . Interestingly, increasing RANKL, but not M-CSF, promoted spreading of WT osteoclasts, whereas the latter cytokine was more effective in the context of LysMRacDKO cells WT and LysMRacDKO BMMs were cultured for 60 hours in M-CSF and RANKL at which time apoptosis was measured by ELISA. (E) WT and LysMRacDKO BMMs were maintained in M-CSF and RANKL for 3 days. The cells were starved of cytokine and serum for 3 hours and exposed to 100ng/ml RANKL, with time. Lysates were immunoblotted for phosphorylated Akt S473 and Akt T308. Total Akt (tAKT) serves as loading control. **P,0.01; ***P,0.001.
(supplementary material Fig. S4 ). This observation is in keeping with the cytoskeleton-organizing effects of M-CSF on osteoclasts lacking the avb3 integrin or its effector Dap12 (Faccio et al., 2003c) .
Rac recognizes most of its target molecules through its 20-amino-acid effector loop (Del Pozo et al., 2002) . To determine whether this region mediates cytoskeletal organization, we transduced LysRacDKO osteoclast precursors with Rac1 constructs containing effector loop point mutations (Fig. 4B ). These mutants include Rac1 T35S, which prevents binding to all known effectors, Rac1 F37A, which does not recognize the effectors Por1 (also known as ARFIP2) and p160ROCK (also known as ROCK1), and Rac1 Y40C, which is unable to bind CRIB-containing effectors such as PAK (Del Pozo et al., 2002) . The transductants were then maintained in M-CSF and RANKL for 4 days before being fixed and stained for TRAP activity (Fig. 4C , left-hand panels). Whereas WT Rac1 completely rescued the inability of the LysRacDKO osteoclasts to spread, none of the mutated constructs was capable of doing so. Confirming the functional consequences of these observations, the capacity of the various transduced LysRacDKO osteoclasts to resorb bone in vitro mirrored their ability to spread (Fig. 4C , right-hand panels). Thus, Rac1 mediates its cytoskeleton organizing properties, in osteoclasts, through its effector region.
These observations suggest that, similar to other avb3-integrin-activated molecules in osteoclasts, absence of Rac1 and Rac2 disorganizes the cytoskeleton. One consequence of this disorganization might be decreased cell migration. To determine whether absence of the GTPase isoforms impacts upon directed or non-directed movement of cells committed to the osteoclast phenotype, we generated pre-fusion osteoclasts by 3 days of exposure to M-CSF and RANKL. The cells were then lifted and placed in transwell filter chambers. Directed movement was assessed by migration towards immobilized vitronectin and DOCDOC , Rac2 2/2 or LysMRacDKO BMMs, on plastic, were differentiated into osteoclasts by 5 days of exposure to M-CSF and RANKL. The cells were stained for TRAP activity. (B,C) WT and mutated Rac1 constructs were retrovirally transduced into LysMRacDKO BMMs. (B) Expression of each transductant was determined by immunoblotting. Empty vector (pmx) transduced into WT and LysMRacDKO BMMs served as a control. (C) Left panels: osteoclasts, generated on plastic were stained for TRAP activity (purple reaction product). Right panels: osteoclasts generated on bone were removed and resorption pits, visualized by wheat-germ-agglutinin-lectin staining, were outlined. (D) WT or LysMDKO BMMs were maintained in M-CSF and RANKL for 3 days to generate pre-fusion osteoclasts. The cells were lifted and placed in the upper chamber of transwell dishes. The lower chamber contained unaltered medium or vitronectin-coated filter surface with or without recombinant h-CSF and RANKL. After 8 hours, the filters were stained with crystal violet and the number of prefusion osteoclasts present on the lower filter surface determined. ***P,0.001 compared with WT. Scale bars: 200 mm (A,C, right-hand panels); 100 mm (C, left-hand panels).
Fig. 5. Cytoskeletal organization of LysMRacDKO osteoclasts is deranged. (A) WT, LysMRac1
DOCDOC , Rac2 2/2 and LysMRacDKO BMMs were cultured on bone slices for 7 days in the presence of M-CSF and RANKL. The actin cytoskeleton was visualized by Alexa-Fluor-488-phalloidin staining. Actin rings are present in WT, LysMRac1 DOCDOC and Rac2 2/2 osteoclasts, and podosomes are dot-like structures in LysMRacDKO osteoclasts.
(B,C) WT and LysMDK osteoclasts were generated on bone slices as detailed in A. The specimens were plastic embedded. (B) Semi-thin sections were prepared. WT osteoclasts (left panel) are juxtaposed to bone in resorption lacunae. By contrast, LysMDKO osteoclasts are thin, elongated and poorly apposed to bone, which they fail to resorb. (C) Transmission electron microscopy demonstrates actin rings (asterisk) encompassing ruffled border (RB) in WT osteoclasts (10,0006 magnification) and absence of both structures in LysMRacDKO cells (20,0006 magnification). Scale bars: 100 mm.
medium containing human CSF (h-CSF) and RANKL. Nondirected migration was determined in the absence of the chemotactic agents. Non-directed movement of LysMRacDKO pre-fusion osteoclasts through a transwell filter was significantly diminished relative to that of WT cells (P,0.001) ( Fig. 4D ; supplementary material Fig. S5 ). However, the magnitude of migration, of both genotypes, induced by chemotaxis was ,2.5-3-fold that of non-induced cells. Therefore, random movement of osteoclastic cells requires Rac, but this GTPase does not regulate their directed migration towards cell-modifying ligands, confirming the data of Wheeler et al. (Wheeler et al., 2006) .
To explore further the role of Rac in structuring the osteoclast cytoskeleton, we examined two key features, namely the formation of the actin ring and ruffled border (Teitelbaum, 2007) . Whereas actin rings were abundant and indistinguishable from WT in osteoclasts lacking either single Rac isoform, they were absent in LysMRacDKO polykaryons generated on bone (Fig. 5A ). In keeping with this observation, podosomes, the mobile adhesive structures that organize to form actin rings in normal bone-residing cells, were distributed throughout the cytoplasm of the double-deleted dysfunctional cells (Saltel et al., 2008) (Fig. 5A) . Interestingly, LysMRacDKO osteoclasts, cultured on bone, were substantially larger than their WT counterparts. Thin, sagittal sections of the mutant cells, generated on bone, demonstrated that their apparent increase in size reflects an attenuation of height (Fig. 5B) . Mirroring in vivo histology (Fig. 1D) , cultured WT cells were closely adherent to the mineralized tissue and produced deep resorption pits, whereas LysMRacDKO osteoclasts were poorly apposed to the bone surface, which they failed to excavate. When visualized by electron microscopy, WT osteoclasts exhibited characteristic ruffled borders surrounded by actin rings, whereas these structures were absent in LysMRacDKO cells (Fig. 5C ).
Deletion of Rac impairs Arp3 localization
The Arp2/3 actin-organizing complex is activated, in other cell types, by Cdc42 and Rac, albeit by distinct mechanisms (Mullins et al., 1998) . To determine whether Arp proteins participate in Rac-mediated organization of their cytoskeleton, we exposed bone-residing cytokine-starved WT and LysMRacDKO osteoclasts to M-CSF, which we established activates Rac. In keeping with the role of Arp proteins in actin-ring generation (Hurst et al., 2004) , Arp3 localized to this structure in WT cells (Fig. 6) . In LysMRacDKO osteoclasts, however, Arp3 was diffusely distributed throughout the cytoplasm. Thus, Rac organizes the osteoclast cytoskeleton, at least in part, through the Arp3 pathway.
Diminished Rac1 exclusively in Rac2
2/2 differentiated osteoclasts causes osteopetrosis LysMCre targets cells throughout the osteoclast lineage. To determine whether inhibiting Rac expression exclusively in cells terminally committed to the resorptive phenotype alters bone morphology, we crossed Rac1 f/f or Rac1 f/f Rac2 2/2 mice to those expressing Cre recombinase driven by the cathepsin K (CatK) promoter, whose activity is a marker of late osteoclastogenesis (Nakamura et al., 2007) . Mice with diminished Rac1 in committed osteoclasts combined with global absence of Rac2 are referred to as CatKRacDKO. As expected, CatK-Cre did not appreciably alter Rac1 f/f abundance until after 3-4 days of exposure to RANKL and M-CSF (Fig. 7A) . After 5 days of cytokine treatment, Rac1 was diminished by 50-60% in CatKRacDKO cultures, which is probably owing to the persistence of mononuclear cells that have yet to activate the Cre recombinase. Multinucleated CatKRacDKO cells spread poorly and had a 'crenated' appearance resembling those lacking other components of the cytoskeleton-organizing complex activated by avb3 integrin (Fig. 7B) . Unlike their LysMRacDKO counterparts, however, actin ring (Fig. 7C ) and resorption pit formation (Fig. 7D) by CatKRacDKO osteoclasts was indistinguishable from WT. Resembling LysMRac1 DOCDOC mice, however, CatKRacDKO animals had the characteristic features of osteopetrosis, including an abundance of cartilaginous bars (Fig. 8A-C) . In keeping with their deficient resorptive activity, in vivo the double-deleted osteoclasts, although abundant, are thin, attenuated and, like those of LysMRacDKO mice, inconsistently abut on bone (Fig. 8D) . For unknown reasons, the teeth of all CatKRacDKO mice failed to erupt, whereas LysMDKO mice are orally unaffected (Fig. 8E) .
Discussion
The unique capacity of the osteoclast to degrade bone reflects its ability to transport protons, chloride ions and cathepsin K into the resorptive microenvironment (Teitelbaum, 2007) . Targeted release of these molecules rests on delivery of lysosome-derived vesicles to the bone-apposed plasma membrane into which they insert under the aegis of exocytic proteins, such as synaptotagmin VII (Zhao et al., 2008) . These polarized structures contain CatK, which is directly discharged into the resorptive space upon vesicle and plasma membrane fusion. The exocytic vesicles also insert an Fig. 6 . Rac regulates Arp3 distribution in osteoclasts. WT and LysMRacDKO osteoclasts, generated on bone, were starved of serum and cytokine and then exposed to M-CSF for 5 minutes. The cells were fixed, and Arp3 was visualized by immunofluorescence. Scale bar: 20 mm. electrogenic proton-transporting H + -ATPase and charge-coupled chloride channel into the targeted plasmalemma domain. Vesicle incorporation greatly enhances plasma membrane complexity, thus forming the ruffled border. Coincidentally, the fibrillar actin of the osteoclast generates a 'gasket-like' ring that surrounds the resorptive microenvironment, isolating it from the general extracellular space and permitting concentration of bonedegrading molecules.
Although these morphological phenomena have been long appreciated, the molecular events initiating them have only recently come to light. In this regard is the important observation that actin ring and ruffled border formation occur only in osteoclasts juxtaposed to bone, indicating that specific intracellular signals originating from mineralized tissue are necessary to restructure the cytoskeleton to its bone resorbing conformation.
Integrins are central to cell and matrix recognition and cytoskeletal organization. The avb3 integrin is the key such heterodimer expressed by the osteoclast, and its absence disorganizes the cytoskeleton and enhances bone mass owing to resorptive inefficiency (McHugh et al., 2000) . Like other examples of augmented bone volume due to osteoclast dysfunction, deletion of the b3 integrin subunit increases the number of TRAP-expressing polykaryons. Because integrins regulate the resorptive process through cytoskeletal organization, attention has turned to the relevant signaling events activated by the heterodimer.
In 1991, Soriano et al. observed that osteopetrosis is the dominant phenotype of Src-deficient mice (Soriano et al., 1991) . The fact that osteoclasts are abundant in these mutants indicates that their function is compromised. In fact, Src 2/2 osteoclasts fail to organize their cytoskeleton, as manifested by impaired spreading and actin ring and ruffled border formation. Src is constitutively associated with avb3 integrin in osteoclasts and activated upon integrin occupancy (Faccio et al., 2003a) . In this context, stimulated Src phosphorylates a second tyrosine kinase, Syk, which is recruited to the integrin cytoplasmic domain by its interaction with the ITAM-domain-containing protein Dap12 (Zou et al., 2007) . In conjunction with the adaptor SLP76, activated Syk phosphorylates the relatively osteoclast-specific GEF Vav3 (Reeve et al., 2009 ). Deletion of any member of this avb3-integrin-activated complex arrests the capacity of the osteoclast to organize its cytoskeleton and resorb bone normally.
We find that M-CSF, which is essential for osteoclast precursor proliferation and survival of the mature polykaryon, induces a signaling complex similar to that stimulated by the integrin, perhaps by transition of avb3 integrin to its high-affinity ligand-binding conformation (Faccio et al., 2003a) . In this regard, M-CSF activates Rac, in these cells, but must do so in the context of the integrin (Faccio et al., 2003b) . Taken together with the fact that Vav3 selectively targets Rac in osteoclasts (Faccio et al., 2005) , a model presents itself whereby M-CSF stimulates avb3 integrin, which in turn induces the integrin-associated signaling complex eventually resulting in Rac activation through GTP association.
Although our previous studies have detailed the mechanisms by which avb3 integrin and M-CSF, in concert, activate Rac, the role of this GTPase in osteoclast function remained undefined. Here, we establish that Rac1 and Rac2 mutually compensate to maintain normal bone structure and osteoclast function. By contrast, deletion of both Rac isoforms results in severe osteopetrosis. Indeed, the osteopetrotic lesion in LysMRacDKO mice is more profound than that prompted by deletion of any other member of the avb3-integrin-associated cytoskeletonorganizing complex save Src. The similarity of the Src and LysMRacDKO phenotypes is underscored by failure of both mutants to generate the key cytoskeletal organelles of functional osteoclasts, namely actin rings and ruffled borders. Although conjectural, the strikingly severe osteopetrosis of Src 2/2 and LysMRacDKO mice might represent the fact that both molecules govern a number of cytoskeletal-organizing pathways, in addition to the canonical avb3-integrin-initiated complex (Sakai et al., 2006) . In contrast to our findings, an earlier report concluded that deletion of both Rac isoforms in macrophages and their osteoclast progeny results in only slight augmentation (,22%) of trabecular bone volume, with no change in bone mineral density (Wang et al., 2008) . Similar to our initial attempts to delete Rac1, in vivo, these investigators used mice expressing a single copy of LysM-Cre. Unlike these authors, we failed to obtain complete deletion of Rac1 using this approach. We were successful, however, using animals containing two copies of LysM-Cre, and we established that Rac1 and Rac2 mutually compensate to maintain normal bone structure and osteoclast function. Moreover, Rac1 is surprisingly efficient in organizing the osteoclast cytoskeleton, as deletion of ,90% of the isoform throughout the osteoclast lineage fails to impact upon the cell, even in the absence of Rac2. Thus, we speculate that the mild phenotype seen by Wang and colleagues reflects persistence of low levels of Rac1.
We have noted that the absence of any member of the avb3-integrin-activated canonical cytoskeleton-organizing complex arrests osteoclast function, but not differentiation, and we find the same holds regarding LysMRacDKO cells. Absence of both Rac isoforms yields an in vitro phenotype similar to deletion of its proximal activators with no evidence of arrested expression of osteoclast maturation markers. The fact that, unlike osteoclasts lacking Cdc42, LysMRacDKO osteoclasts are abundant in vivo, buttresses the conclusion that differentiation of the cell is not altered. Furthermore, in keeping with the observations of Fukuda et al., Rac suppression in osteoclastic cells promotes apoptosis (Fukuda et al., 2005) . Although the mechanism of this event is yet to be determined, it might represent compromised binding of the avb3 integrin to its immobilized ligand, which promotes programmed death of the bone resorptive cell (Fukuda et al., 2005; Zhao et al., 2005 ).
The osteoclast is of the monocyte and macrophage lineage, all of whose members express LysM. Hence, using LysMCre mice does not establish whether the targeted gene alters osteoclast function in the context of the mature resorptive cell as compared with its noncommitted precursors. To resolve this issue, we turned to mice transgenic for Cre recombinase driven by the CatK promoter whose transactivation is confined to cells with terminal commitment to the osteoclast phenotype (Nakamura et al., 2007) . Supporting our conclusion that RacDKO osteoclasts differentiate normally, CatKRacDKO mice develop osteopetrosis. Unlike their LysMRacDKO counterparts, however, CatKRacDKO osteoclasts, generated in culture, generate actin rings and resorb bone. We were therefore surprised that arrested tooth eruption, a sign of severe osteopetrosis, is evident in CatKRacDKO, but not LysMRacDKO, animals. We have noted a similar inconsistency of in vitro and in vivo phenotype severity in other circumstances of cathepsin-K-driven Cre-mediated gene deletion in osteoclasts (W.Z., unpublished data). Although the mechanism of this discrepancy is unknown, it might relate to the continuous incorporation of macrophage progenitors into cultured osteoclasts. As cathepsin-K-driven Cre would be ineffective in these non-committed osteoclast precursors, a reasonable hypothesis holds that these mononuclear cells are delivering intact osteoclast-modulating genes into mature polykaryons in which they are actively targeted. Additionally, the assumption that the temporal course of CatK-mediated gene deletion in vivo mirrors that in vitro might not be true. Thus, earlier activation of the cathepsin K promoter in vivo can account for the more severe phenotype than that encountered in vitro.
The morphology of both LysMRacDKO and CatKRacDKO osteoclasts in vivo is abnormal, with features indicative of cytoskeletal dysfunction, such as inability to adhere to bone. The appearance of each, however, differs from the other. LysMRacDKO cells are reminiscent of those encountered in human osteopetrosis, in that they are large and irregular, whereas CatKRacDKO osteoclasts mirror double deleted cells cultured on bone (Coccia et al., 1980) . We cannot account for these differences but they probably reflect targeting of Rac isoforms throughout the osteoclast lineage by LysMCre and only in mature cells, by CatKCre.
Although both Rac and Cdc42 target the osteoclast, their impact upon the resorptive cell is distinct. Specifically, the magnitude of osteopetrosis in CatKRacDKO animals is more substantial than in their Cdc42-knockout counterparts (Ito et al., 2010) . Furthermore, Cdc42 deficiency modestly affects the osteoclast cytoskeleton through atypical PKCs, with its most profound consequence being a reduction in cell number caused by inhibition of osteoclast precursor proliferation and accelerated apoptosis of the mature resorptive polykaryon. RacDKO mice also have diminished numbers of osteoclasts in vitro (but not in vivo) but the dominant effect of loss of this GTPase is impaired function of the differentiated cell. We also find the effector molecule Arp3, which is activated by both GTPases, is misplaced in RacDKO osteoclasts. Thus, Cdc42 is not sufficient, and Rac is required, to localize the Arp2/3 complex to the actin ring. These results indicate that Rac plays a crucial role in activating effector pathways mediating cytoskeleton structuring. Hence, the early observations that Src and avb3 integrin organize the osteoclast cytoskeleton have prompted insights into a canonical complex in which Rac governs resorptive activity.
Materials and Methods
Antibodies
Mouse anti-Rac1 (clone 23a8), rabbit anti-Rac2 and mouse anti-cathepsin-K antibodies were from Millipore. Antibodies against b3 integrin (mouse), phosphorylated AKT S473 (rabbit), phosphorylated AKT T308 (rabbit) and total AKT (rabbit) were from Cell Signaling. Mouse anti-b-actin antibody was from Sigma. Mouse anti-hemagglutinin (HA) antibody was from Covance. Alexa-Fluor-488-phalloidin was from Invitrogen. Mouse anti-Src antibody was provided by Andrey Shaw (Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO).
Mice
Rac1
f/f (Gu et al., 2003) and Rac2 2/2 (Roberts et al., 1999 ) mice were as previously described. LysM-Cre mice were purchased from Jackson Labs and are on a C57BL/6 background. CatK-Cre mice were a gift from Shigeaki Kato (University of Tokyo, Tokyo, Japan) and are on a C57BL/6 background (Nakamura et al., 2007) . All mice were housed in the animal facility at Washington University School of Medicine and maintained according to the guidelines set by the Association for Assessment and Accreditation of Laboratory Animal Care. All animal studies were approved by the Animal Studies Committee of Washington University School of Medicine.
To obtain Rac1 and Rac2 double-knockout mice, we first crossed the Rac1 f/f and Rac2 2/2 mice to obtain Rac2-null animals carrying the floxed Rac1 allele (Rac1
). These animals were then crossed to either the LysM-Cre or CatK-Cre strain to target the floxed Rac1 allele for deletion. To fully delete Rac1 using LysM-Cre, Rac1 f/f Rac2 2/2 LysMCre +/2 mice were crossed again to obtain animals bearing two copies of the LysM-Cre allele (Rac1 f/f Rac2 2/2 LysMCre +/+ ). The same strategy was used to obtain LysMRac1 DOCDOC mice. Rac1 f/f Rac2 +/+ mice were used as wild-type controls for all experiments.
Quantitative PCR Rac1 expression was assessed using quantitative PCR. Cyclophilin was used as the housekeeping control gene. RNA was collected from cultured macrophages using RNeasy kit (Qiagen). 1 mg of RNA was used for cDNA synthesis (Finnzymes). Primers for Rac1 were: 59-GTGCTCAGCTCTCACACAGC-39 and 59-CAGC-AGGCATTTTCTCTTCC-39. Primers for cyclophilin were: 59-AGCATACA-GGTCCTGGCATC-39 and 59-TTCACCTTCCCAAAGACCAC-39. PCR analysis utilized Syber Green as the reporter (Finnzymes) and relative expression of Rac1 was calculated using the DDC T method.
Histology
Following killing by CO 2 inhalation, the tibia were isolated and fixed in 10% phosphate-buffered formalin (Fisher) for 24 hours followed by decalcification in 14% EDTA pH 7.2 for 7 days. Decalcified bones were stored in 70% ethanol and paraffin embedded before sectioning. Sections were stained for TRAP and Toluidine Blue to identify osteoclasts and cartilage, respectively.
Micro-CT and viva-CT analysis
The trabecular volume in the distal femoral metaphysis was measured using a Scanco mCT40 scanner (Scanco Medical AG, Basserdorf, Switzerland). A threshold of 300 was used for evaluation of all scans and 60 slices were analyzed, starting with the first slice in which condyles and primary spongiosa were no longer visible.
For live animal studies, we used a Scanco VivaCT 40 scanner (Scanco Medical AG, Basserdorf, Switzerland). Mice were anesthetized using isofluorane before and during all scans. 100 slices were collected for reconstruction, with a threshold of 135 for samples taken at 4 weeks and a threshold of 140 for samples taken at 7 weeks.
Macrophage isolation and osteoclast culture
Following killing by CO 2 inhalation, long bones were isolated and flushed with a-MEM (Sigma). Whole bone marrow was cultured on bacterial plastic, which promotes growth of monocyte cells and prevents adherence of mesenchymal cells. The cells were cultured with a-MEM containing 10% inactivated fetal bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin, (a-10 medium) supplemented with 1:10 CMG (conditioned medium supernatant containing recombinant M-CSF). On day four of culture, the remaining cells, selected for as a pure population of macrophages, were lifted using 16 trypsin in EDTA and re-plated at 1.5610 4 cells in a tissue-culture treated plastic 48-well plate in a-10 medium supplemented with 100 ng/ml GST-RANKL and 1:50 CMG and cultured over time (3-6 days) and stained for TRAP (Sigma).
For actin ring and pit resorptive assays, cells were cultured as described above on bovine bone slices. Actin rings were visualized using Alexa-Fluor-488-phalloidin (Invitrogen) after fixation in 4% paraformaldehyde and permeablization with 0.1% Triton X-100. To measure resorption, medium from osteoclasts cultured on bone slices was collected and analyzed using CrossLaps for Culture ELISA (Nordic). To assess resorptive pit formation, bone slices, from which cells had been removed by mechanical agitation, were incubated with peroxidaseconjugated wheat germ agglutinin (WGA) (Sigma-Aldrich) and stained with 3,39-diaminobenzidine (Sigma-Aldrich).
For cytokine stimulation assays, macrophages were re-plated at a density of 1.5610 6 cells per plate in 100-cm tissue culture treated plates and cultured in a-10 medium supplemented with 1:50 CMG and 100 ng/ml GST-RANKL for 3 days to form pre-fusion osteoclasts. Cells were cytokine starved in a-MEM for 3 hours before cytokine stimulation using 100 ng/ml RANKL and samples were collected 5, 15, 30, and 60 minutes post stimulation and processed for western blot analysis.
Plasmids and retroviral transduction
Rac1-pCMV-Sport6 was obtained from the ATCC and subcloned into pMX-IRES-BSR by introducing the BamHI 59 and XhoI 39 restriction sites with a hemagglutinin (HA) tag at the 59 end. Primers were: 59-ATATGGATCCATGTA-TCCTTACGATGTGCCTGATTATGCACAGGCCATCAAGTGTGTGG-39 and 59-ATATCTCGAGTTACAACAGCAGGCATTTTCTCTTCC-39.
The T35S, F37A and Y40C mutations were introduced using standard molecular biology techniques. Primers were: T35S 59-CCAGCGTCTTTGACAACTAT-TCTGCCAATG-39 and 59-GTCAAAGACGCTGGGGATGTACTCTCCAGG-39; F37A 59-CCGTCGCTGACAACTATTCTGCCAATGTTATG-39 and 59-GTTGT-CAGCGACGGTGGGGATGTACTCTCC-39; Y40C 59-GACAACTGTTCTGCC-AATGTTATGGTAGATG-39 and 59-GGCAGAACAGTTGTCAAAGACGGTG-GGGATG-39. 8 mg of the pMX retroviral vector was transfected into plat-E packaging cell line using the Transfectol reagent (GeneChoice) according to the manufacturer's instructions. The viral supernatant was collected 48 hours posttransfection and added to BMMs in a-10 with 1:10 CMG and 4 mg/ml polybrene (Sigma-Aldrich). After a 24-hour incubation with the virus, transduced cells were selected using 1 mg/ml blasticidin (Calbiochem) for 3 days and plated for osteoclast precursors as described above.
Western blotting
Cells were washed with ice-cold PBS and lysed in RIPA buffer containing 20 mM Tris-HCl pH 7.5; 150 mM NaCl; 1 mM EDTA; 1 mM EGTA; 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate; 1 mM sodium orthovanadate, 1 mM sodium fluoride and 16 protease inhibitor cocktail (Roche). After a 10-minute incubation on ice, lysates were cleared of debris by a 10-minute centrifugation at 20,800 g. 30-40 mg were subjected to SDS-PAGE (8% gels) and transferred onto a PVDF membrane. Following blocking with 0.1% casein in PBS, primary antibodies were incubated overnight at 4˚C and probed with fluorescent-labeled secondary antibodies (Jackson) and detected on the Odyssey Infrared Imaging System (LI-COR Biosciences). Densitometry was performed using Image J software.
Migration assay
Vitronectin (Millipore) was prepared in sterile PBS (5 mg/ml final concentration) and used to coat the bottom of Transwell 5-mm polycarbonate permeable supports (Corning). Following vitronectin coating, the supports were washed with PBS and blocked using 0.5% BSA in PBS. Day 3 preosteoclasts grown on petri dish plastic were lifted using trypsin-EDTA, washed in a-MEM+2%HIFBS (a-2) and 1610 5 cells were used per well for the migration assay. The bottom chamber contained a-2 or a-2 supplemented with purified recombinant h-CSF (200 ng/ml) and GST-RANKL (200 ng/ml). Plates were incubated at 37˚C for 8 hours, the medium was removed, the filters fixed using 4% paraformaldehyde and the cells were stained with crystal violet. Cells attached to the upper membrane were removed using a cotton swab. Filters were analyzed for cell migration using standard microscopy and counting five fields per filter using a 206 objective.
Proliferation and apoptosis
Macrophages were plated in 96-well tissue culture plates at a density of 5610 3 per well in a-10 medium supplemented with 1:50 CMG and 100 ng/ml RANKL. Proliferation assays were conducted on day 2 and day 3 of culture using a Cell Proliferation ELISA kit (Amersham). Apoptosis assays were conducted 60 hours following plating using the Cell Death Detection ELISA kit (Roche).
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